Structure (Nabumetone 1)
Nabumetone Tablet, Film Coated
Product Images NDC 69097-965
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Nabumetone (NDC 69097-965). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Cipla Usa Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
6mna (Nabumetone 2)
Figure (Nabumetone 3)
This is a graph showing the plasma concentrations of Nabumetone active metabolite at steady state following once-daily doses of either 1000 mg or 2000 mg. The x-axis shows time in hours, and the y-axis shows concentration in mg/mL. The graph shows that the concentration of Nabumetone active metabolite increases with the dose and peaks at around 7-8 hours after dosing. The standard deviations for the concentrations are also shown.*
This Is A Picture Of The Label Nabumetone Tablets, Usp, 750 mg, 100 Count (Nabumetone 500 mg Asc)
Nabumetone Tablets are a prescription drug that comes in a pack of 100 tablets, with each tablet containing 500 mg of nabumetone USP. It is commonly used as a pain reliever and anti-inflammatory medication. Each patient is supposed to receive medication guidelines, as per the pharmacist's attention. It is manufactured by Ascent Pharmaceuticals, Inc. with the purpose of Cipla USA Inc. It is suggested to be stored in a light-resistant container within the USP-controlled room temperature range of 20-25 °C. The text also includes Pharmacy information for Dispensing the medication.*
This Is A Picture Of The Label Nabumetone Tablets, Usp, 500 mg, 100 Count (Nabumetone 500 mg Inv)
This is a description of nabumetone tablets, a prescription medication by Cipla US. Each tablet contains 500 mg of nabumetone, and the usual dosage information is provided in the package insert. A medication guide is required for each patient. The tablets should be stored between 20-25°C and kept out of the reach of children in a tightly sealed and light-resistant container. The manufacturer is InvaGen Pharmaceuticals, Inc., a subsidiary of Cipla Lic. The tablets come in a bottle containing 100 units. The lot number is not discernible.*
This Is A Picture Of The Label Nabumetone Tablets, Usp, 500 mg, 100 Count (Nabumetone 750 mg Asc)
This Is A Picture Of The Label Nabumetone Tablets, Usp, 500 mg, 100 Count (Nabumetone 750 mg Inv)
Nabumetone is a prescription drug that comes in the form of tablets. Each tablet contains 750mg of nabumetone USP. Patients must receive a medication guide. The package insert should be seen for full prescribing information. The tablets must be stored at 20 to 25°C (68 to 77°F) and dispensed in a tightly closed, light-resistant container with a child-resistant closure. Nabumetone is manufactured by InvaGen Pharmaceuticals, Inc, a subsidiary of Cipla Limited, while Cipla USA, Inc distributes it in a 100 tablet bottle. Keep this and all medications out of the reach of children.*
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
